产品详情
英文名称 RGS4
中文名称 精神分裂症相关蛋白9抗体
别 名 Regulator of G protein signalling 4; Regulator of G-protein signaling 4; RGP 4; RGP-4; RGS 4; RGS4; RGS4_HUMAN; Schizophrenia disorder 9; SCZD 9; SCZD9; MGC2124; MGC60244.
精神分裂症相关蛋白9抗体
说 明 书 0.2ml
研究领域 心血管 神经生物学 信号转导 G蛋白信号
抗体来源 Rabbit
克隆类型 Polyclonal
交叉反应 Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep,
产品应用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 (石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 23kDa
性 状 Lyophilized or Liquid
浓 度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human RGS4
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
精神分裂症相关蛋白9抗体产品介绍 background:
Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(z)-alpha is inhibited by phosphorylation of the G-protein. Activity on G(z)-alpha and G(i)-alpha-1 is inhibited by palmitoylation of the G-protein.
Function:
Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(z)-alpha is inhibited by phosphorylation of the G-protein. Activity on G(z)-alpha and G(i)-alpha-1 is inhibited by palmitoylation of the G-protein.
Tissue Specificity:
Expressed in brain and heart. Expressed in brain at protein level. Expressed in prefontal and visual cortex. Isoform 4 and isoform 5 are expressed ubiquitously. Isoform 1, isoform 2 and isoform 3 are not expressed in the cerebellum.
Post-translational modifications:
Palmitoylated on Cys-2 and/or Cys-12.
Phosphorylated by cyclic GMP-dependent protein kinase (By similarity).
DISEASE:
Genetic variation in RGS4 is associated with susceptibility to schizophrenia type 9 (SCZD9) [MIM:604906]. A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder.
Database links:
Entrez Gene: 5999 Human
Entrez Gene: 19736 Mouse
Entrez Gene: 29480 Rat
Omim: 602516 Human
SwissProt: P49798 Human
SwissProt: O08899 Mouse
SwissProt: P49799 Rat
Unigene: 386726 Human
Unigene: 41642 Mouse
Unigene: 11065 Rat
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Involvement in disease;Genetic variation in RGS4 is associated with susceptibility to schizophrenia type 9 (SCZD9) . A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder.
精神分裂症相关蛋白9抗体
hz-6564R GPR171/Platelet Activating Receptor H963 G蛋白偶联受体171抗体
hz-6565R POT1 端粒保护蛋白1抗体
hz-6566R PRSS3 脑胰蛋白酶3抗体
hz-6567R HDBP2/PTTG1IP 乳头瘤病毒调控因子1抗体(锌指蛋白395)
hz-6568R PCANAP2/Prostein 前列腺癌相关蛋白2抗体
hz-6569R RLBP1L1 视黄醛结合蛋白1抗体
hz-6570R RING5 环指蛋白5抗体(E3泛素蛋白连接酶RNF5)
hz-6571R RPL15 核糖体蛋白L15抗体
hz-6572R RPL19 核糖体蛋白L19抗体
hz-6573R RPL5 核糖体蛋白L5抗体
hz-6574R RRBP1 核糖体结合蛋白1抗体
hz-6575R S100A7/Psoriasin S100钙结合蛋白A7抗体
hz-6576R RBBP6 视网膜母细胞瘤结合蛋白6抗体
hz-6577R S100PBP/S100P binding protein S100P结合蛋白抗体
hz-6578R SAMD14 SAMD14抗体
hz-6580R CDMP1/GDF5 软骨衍生形态发生蛋白1抗体
hz-6581R RNA polymerase II CTD repeat YSPTSPS (phospho S2) 磷酸化RNA聚合酶II CTD抗体
hz-6582R RNA polymerase II CTD repeat YSPTSPS (phospho S5) 磷酸化RNA聚合酶II CTD抗体
hz-6583R RNASE4/Angiogenin 血管生成素核糖核酸酶4抗体(肌萎缩性侧索硬化症蛋白)
hz-6584R DUT 脱氧尿苷三磷酸酶DUT抗体
hz-6585R Desmoglein 3/DSG3 桥粒芯蛋白3抗体
hz-6586R FCAR/CD89 免疫球蛋白A Fc段受体1抗体
hz-6587R APEX2 嘌呤嘧啶核酸内切酶2抗体
hz-6588R ADAMTS10 整合素样金属蛋白酶与凝血酶10型抗体
hz-6589R BCAT2/BCAM 支链氨基酸转氨酶2抗体
hz-6590R Bcl2A1 BCL2相关蛋白A1抗体
hz-6591R Bcl3 B细胞淋巴瘤蛋白3抗体
hz-6592R HSD17B6 17-β-羟脱氢酶6抗体
hz-6593R TFF1/BCEI 乳腺癌雌激素诱导蛋白抗体
hz-6594R Galectin 1 半乳糖凝集素1抗体
hz-6595R CENPB 着丝粒蛋白B抗体
hz-6596R STMN3 原癌基因18家族STMN3蛋白抗体
hz-6597R NPHS2/Podocin 肾小球裂孔膜蛋白PDCN抗体
hz-6598R Cofilin 肌动蛋白结合蛋白CFL抗体
hz-6599R EphA5/Eph receptor A5 酪氨酸蛋白激酶A5受体抗体
hz-6600R HHEX/HMPH 同源盒蛋白PRH抗体
hz-5164R ETS1 associated protein II/EAPII ETS1相关蛋白2抗体
hz-6601R TLR7 Toll样受体7抗体
hz-6603R HSD17B1/HSD17 羟类固醇脱氢酶17β抗体
hz-6604R BCNG1/HCN1 脑环核苷酸门控通道蛋白1抗体
hz-6605R BCAS3 乳腺癌相关蛋白3抗体